Advertisement
Screener

NORTHWEST BIOTHERAPEUTICS INC (NWBO) Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period

1.9 / 5 stars · 39/103 Roast Me

NORTHWEST BIOTHERAPEUTICS INC Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period

New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.

  • NORTHWEST BIOTHERAPEUTICS INC share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2024-12-31 was 0.00 shares, a 100.00% decline year-over-year.
  • NORTHWEST BIOTHERAPEUTICS INC share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2024-09-30 was 0.00 shares, a 100.00% decline year-over-year.
  • NORTHWEST BIOTHERAPEUTICS INC share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2024-06-30 was 0.00 shares, a 100.00% decline year-over-year.
  • NORTHWEST BIOTHERAPEUTICS INC share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2024-03-31 was 650.00K shares, a 50.94% decline year-over-year.
  • NORTHWEST BIOTHERAPEUTICS INC share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2024 was 650.00K shares, a 83.15% decline from fiscal 2023.
  • NORTHWEST BIOTHERAPEUTICS INC share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2023 was 3.86M shares, a 13.37% increase from fiscal 2022.
  • NORTHWEST BIOTHERAPEUTICS INC share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2022 was 3.40M shares, a 1759.02% increase from fiscal 2021.
  • NORTHWEST BIOTHERAPEUTICS INC share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2021 was 183.00K shares, a 94.68% increase from fiscal 2020.
Period endShare-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 3 monthShare-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 12 month
2024-12-310.00 shares
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31
650.00K shares
10-K · filed 2025-03-31
2024-09-300.00 shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12
2.00M shares
derived: sum of 4 quarters · filed 2025-03-31
2024-06-300.00 shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-09
2.68M shares
derived: sum of 4 quarters · filed 2025-03-31
2024-03-31650.00K shares
10-Q · filed 2024-05-10
3.18M shares
derived: sum of 4 quarters · filed 2025-03-31
2023-12-311.35M shares
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31
3.86M shares
10-K · filed 2025-03-31
2023-09-30680.00K shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09
-2.28M shares
derived: sum of 4 quarters · filed 2024-03-05
2023-06-30502.00K shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09
1.94M shares
derived: sum of 4 quarters · filed 2024-03-05
2023-03-311.32M shares
10-Q · filed 2023-05-10
2022-12-31-4.79M shares
derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-05
3.40M shares
10-K · filed 2024-03-05
2022-09-304.90M shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09
2021-12-31178.62K shares
derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-05
183.00K shares
10-K · filed 2024-03-05
2021-09-30588.00 shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15
2021-06-3093.00 shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-16
2021-03-313.69K shares
10-Q · filed 2021-05-17
2020-12-3194.00K shares
10-K · filed 2023-02-28
2015-03-31888.19K shares
10-K · filed 2017-04-17
2014-09-30497.13K shares
10-K · filed 2016-03-16
2014-06-3092.10K shares
10-K · filed 2016-03-16
2012-12-310.00 shares
10-K · filed 2013-04-08